ABBV-101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABBV-101, covering 2025-10-02 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies [Phase 1]